Man Group PLC Global Blood Therapeutics, Inc. Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$32.4 - $68.18 $20.7 Million - $43.6 Million
639,097 New
639,097 $43.5 Million
Q2 2021

Aug 16, 2021
SELL
$32.46 - $43.42 $571,620 - $764,626
-17,610 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$38.94 - $50.85 $2.36 Million - $3.08 Million
-60,543 Reduced 77.47%
17,610 $718,000
Q4 2020

Feb 16, 2021
BUY
$37.65 - $63.77 $1.21 Million - $2.04 Million
32,052 Added 69.53%
78,153 $3.39 Million
Q3 2020

Nov 16, 2020
SELL
$52.76 - $74.49 $1.6 Million - $2.25 Million
-30,256 Reduced 39.62%
46,101 $2.54 Million
Q2 2020

Aug 14, 2020
BUY
$48.73 - $81.82 $3.25 Million - $5.46 Million
66,757 Added 695.39%
76,357 $4.82 Million
Q1 2020

May 15, 2020
SELL
$41.72 - $87.2 $290,579 - $607,348
-6,965 Reduced 42.05%
9,600 $490,000
Q4 2019

Feb 18, 2020
SELL
$45.7 - $81.86 $1.76 Million - $3.15 Million
-38,488 Reduced 69.91%
16,565 $1.32 Million
Q3 2019

Nov 14, 2019
BUY
$45.35 - $57.91 $2.5 Million - $3.19 Million
55,053 New
55,053 $2.67 Million
Q2 2019

Aug 14, 2019
SELL
$52.6 - $63.29 $2.05 Million - $2.46 Million
-38,887 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$39.99 - $53.48 $1.56 Million - $2.08 Million
38,887 New
38,887 $2.06 Million
Q4 2018

Feb 14, 2019
SELL
$31.54 - $46.67 $249,197 - $368,739
-7,901 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$38.0 - $51.1 $39,026 - $52,479
-1,027 Reduced 11.5%
7,901 $300,000
Q2 2018

Aug 14, 2018
SELL
$38.7 - $50.15 $777,637 - $1.01 Million
-20,094 Reduced 69.24%
8,928 $403,000
Q1 2018

May 15, 2018
BUY
$39.6 - $65.9 $1.15 Million - $1.91 Million
29,022 New
29,022 $1.4 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email